Skip to content

Docrates is the first to launch a new type of alpha radiation therapy in the Nordic region

24.6.2024 Categories: News
Treatments
Docrates Cancer Center is the first service provider in the Nordic region to launch a new experimental alpha radiation treatment for patients with metastatic prostate cancer. Alpha radiation therapy can be administered as a stand-alone treatment or combined with beta radiotherapy for more effective cancer treatment.

Alpha radiation is an experimental type of radiotherapy that is being studied as a viable option for treating prostate cancer, the most common cancer in men, in situations where castration-resistant prostate cancer has metastatised and standard forms of therapy are not effective. High-energy alpha radiation is more effective at destroying cancer tissue, and the treatment is also better at targeting micrometastases, compared to beta radiation.

In 2017, Docrates Cancer Center introduced isotope treatments, in other words, radiotherapy, for the treatment of metastatic prostate cancer. Almost 1,500 Docrates patients have already received radiotherapy. According to the latest research*, alpha radiation treatments can achieve good responses in patients with an extensively metastatic cancer or who have had an inadequate response to beta radiation-based isotope therapy. The combination of isotope therapies based on alpha and beta radiation has also shown promising preliminary results.

– We are excited to become the first service provider in the Nordic region to introduce new types of alpha radiation treatments. Our solutions for treating metastatic prostate cancer include hormone therapy and chemotherapy, as well as radiotherapy and isotope therapy.  However, cancer can change and an individual medicine or treatment may lose its effectiveness. Cancer treatment often requires a combination of different treatments, and alpha radiation therapy is a welcome addition to this arsenal, says Juha Kononen, Chief Clinical Director at Docrates Cancer Center.

– We are now on the verge of something new. Alpha radiation is an effective type of particle radiation that can now be used as an individual form of therapy for people with prostate cancer. The research results of the treatments are very promising, says Jukka Kemppainen , Chief Physician in Nuclear Medicine at Docrates Cancer Center.

Docrates Cancer Center uses the latest international research data in the individual treatment of patients with cancer and introduces new diagnostic methods and treatments as soon as they become available.

*Learn more about the study here >

For more information, please contact:
Juha Kononen, Chief Clinical Director
Docrates Cancer Center

Read the stories of our cancer patients

Hannu Nurmio: Aiming for a normal everyday life

When rock musician Hannu "Tuomari" Nurmio, 73, learned that his PSA values were elevated, he decided to go for an...

Read more

The story of a breast cancer patient: You have to focus on the good things, even if the world keeps spinning

It is December, and the first long year of the pandemic is nearing its end. A couple is sitting in...

Cancer diagnosis did not stop Mika Piltz: “I’m grateful that quality of life can be improved with the right treatment methods”

Getting diagnosed with prostate cancer turned the world of Mika Piltz, 54, upside down in 2021. His calendar was filled...

Janos Uotila’s prostate cancer was treated in a private cancer hospital

There's a man in the hospital lobby with a smile on his face. Janos Uotila, 45, has become familiar with...

Why come to Docrates Cancer Center?

  • Top cancer experts and effective treatments without delay.
  • Individual care. You have your own care team - your doctor and your nurse.
  • Front line cancer treatment. Latest medical technology combined with proven expertise in cancer care.
  • Experience in treating international patients from over 60 countries. Multilingual personnel.
+358 10 773 2010

Contact us!

Mon-Thu 8:00-18:00, Fri 8:00-16:00